ticlopidine has been researched along with Thrombophilia in 37 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Thrombophilia: A disorder of HEMOSTASIS in which there is a tendency for the occurrence of THROMBOSIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We tested the hypothesis that combined pre-treatment with aspirin and clopidogrel is a risk factor for thrombolysis-related symptomatic intracerebral hemorrhage (sICH)." | 7.75 | Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? ( Dzialowski, I; Gahn, G; Hermann, A; Koch, R, 2009) |
| "Hypercoagulability was seen 5 days after OPCAB and could not be demonstrated after 1 month." | 6.73 | Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel. ( Bochsen, L; Nielsen, AB; Steinbrüchel, DA, 2007) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 5.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| "A total of 55 patients with a history of thrombosis and SPS phenotype were prospectively studied before and after treatment with aspirin and/or clopidogrel." | 5.20 | Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome. ( García-Chavez, J; Hernández-Reyes, J; Rosales-Padrón, J; Ruiz-Arguelles, A; Ruiz-Argüelles, GJ; Ruiz-Delgado, GJ; Vargas-Espinosa, J; Velázquez-Sánchez-de-Cima, S; Zamora-Ortiz, G, 2015) |
| " We tested the hypothesis that combined pre-treatment with aspirin and clopidogrel is a risk factor for thrombolysis-related symptomatic intracerebral hemorrhage (sICH)." | 3.75 | Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke? ( Dzialowski, I; Gahn, G; Hermann, A; Koch, R, 2009) |
| "TEG-Hypercoagulability is defined as a TEG maximum amplitude above 69 mm." | 2.77 | Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study pr ( Johansson, PI; Kofoed, K; Lilleør, NB; Rafiq, S; Steinbrüchel, DA; Stissing, T; Zacho, M, 2012) |
| "Hypercoagulability was seen 5 days after OPCAB and could not be demonstrated after 1 month." | 2.73 | Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel. ( Bochsen, L; Nielsen, AB; Steinbrüchel, DA, 2007) |
| "Eptifibatide was administered as two 180 microg/kg boluses 10 minutes apart followed by a continuous infusion of 2." | 2.70 | Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention. ( Ball, SA; Dauerman, HL; Desourdy, MA; Furman, MI; Goldberg, RJ, 2002) |
| " In order to achieve the desired results and, as with all medications, PPIs should always be used appropriately taking care never to exceed correct dosage and duration." | 2.47 | Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections. ( Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A, 2011) |
| "Stasis ulcers are commonly the result of chronic venous insufficiency." | 1.31 | Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report. ( Bick, RL; Scott, RG, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (5.41) | 18.2507 |
| 2000's | 20 (54.05) | 29.6817 |
| 2010's | 15 (40.54) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeeb, N | 1 |
| Gupta, R | 1 |
| Schneider, AM | 1 |
| Leadon, M | 1 |
| Enriquez, A | 1 |
| Griessenauer, CJ | 1 |
| Salem, M | 1 |
| Alturki, A | 1 |
| Schmalz, P | 1 |
| Ogilvy, CS | 1 |
| Thomas, AJ | 1 |
| Moore, JM | 1 |
| Wernly, B | 1 |
| Lichtenauer, M | 1 |
| Hoppe, UC | 1 |
| Lauten, A | 1 |
| Navarese, EP | 1 |
| Jung, C | 1 |
| Zhao, X | 1 |
| Wu, H | 1 |
| Xu, H | 1 |
| Shen, L | 1 |
| Fan, B | 1 |
| Ge, J | 1 |
| Velázquez-Sánchez-de-Cima, S | 1 |
| Zamora-Ortiz, G | 1 |
| Hernández-Reyes, J | 1 |
| Vargas-Espinosa, J | 1 |
| García-Chavez, J | 1 |
| Rosales-Padrón, J | 1 |
| Ruiz-Delgado, GJ | 1 |
| Ruiz-Arguelles, A | 1 |
| Ruiz-Argüelles, GJ | 1 |
| Glenn, JR | 1 |
| Dovlatova, N | 1 |
| White, AE | 1 |
| Dhillon, K | 1 |
| Heptinstall, S | 1 |
| Fox, SC | 1 |
| Blann, AD | 1 |
| Skjøth, F | 1 |
| Rasmussen, LH | 1 |
| Larsen, TB | 1 |
| Lip, GY | 2 |
| Siasos, G | 1 |
| Oikonomou, E | 1 |
| Zaromitidou, M | 1 |
| Kioufis, S | 1 |
| Kokkou, E | 1 |
| Mourouzis, K | 1 |
| Vlasis, K | 1 |
| Vavuranakis, M | 1 |
| Stone, PH | 1 |
| Papavassiliou, AG | 1 |
| Tousoulis, D | 1 |
| Smilowitz, NR | 1 |
| Berger, JS | 1 |
| Wang, L | 1 |
| Bi, Y | 1 |
| Cao, M | 1 |
| Ma, R | 1 |
| Wu, X | 1 |
| Zhang, Y | 2 |
| Ding, W | 1 |
| Liu, Y | 1 |
| Yu, Q | 1 |
| Jiang, H | 1 |
| Sun, Y | 1 |
| Tong, D | 1 |
| Guo, L | 1 |
| Dong, Z | 1 |
| Tian, Y | 1 |
| Kou, J | 1 |
| Shi, J | 1 |
| Damanti, S | 1 |
| Artoni, A | 1 |
| Lucchi, T | 1 |
| Mannucci, PM | 1 |
| Mari, D | 1 |
| Bergamaschini, L | 1 |
| Lee, R | 1 |
| Hermann, A | 1 |
| Dzialowski, I | 1 |
| Koch, R | 1 |
| Gahn, G | 1 |
| Healey, JS | 1 |
| Apostolakis, S | 1 |
| Shantsila, E | 1 |
| Lane, DA | 1 |
| Albanese, A | 1 |
| Esposito, G | 1 |
| Puca, A | 1 |
| Tuttolomondo, A | 1 |
| Tirpakova, B | 1 |
| Di Giuda, D | 1 |
| Maira, G | 1 |
| Di Lazzaro, V | 1 |
| Kozuma, K | 1 |
| Ota, Y | 1 |
| Nagai, Y | 1 |
| Katsuta, Y | 1 |
| Nozaki, E | 1 |
| Onodera, T | 1 |
| Ikari, Y | 1 |
| Kotani, J | 1 |
| Kyo, E | 1 |
| Yokoi, H | 1 |
| Nakamura, M | 1 |
| Laria, A | 1 |
| Zoli, A | 1 |
| Gremese, E | 1 |
| Ferraccioli, GF | 1 |
| Cardona, L | 1 |
| Ana, G | 1 |
| Luísa, B | 1 |
| Leal, A | 1 |
| António, F | 1 |
| Lídia, S | 1 |
| Cruz, FR | 1 |
| Rafiq, S | 1 |
| Johansson, PI | 1 |
| Zacho, M | 1 |
| Stissing, T | 1 |
| Kofoed, K | 1 |
| Lilleør, NB | 1 |
| Steinbrüchel, DA | 2 |
| Dauerman, HL | 1 |
| Ball, SA | 1 |
| Goldberg, RJ | 1 |
| Desourdy, MA | 1 |
| Furman, MI | 1 |
| Bick, RL | 2 |
| Alfar, H | 1 |
| Goedecke, C | 1 |
| Tsakiris, DA | 1 |
| Brener, SJ | 1 |
| Moliterno, DJ | 1 |
| Lincoff, AM | 1 |
| Steinhubl, SR | 1 |
| Wolski, KE | 1 |
| Topol, EJ | 1 |
| Perneby, C | 1 |
| Wallén, NH | 1 |
| Hu, H | 1 |
| Li, N | 1 |
| Hjemdahl, P | 1 |
| Leopold, JA | 1 |
| Antman, EM | 1 |
| Savi, P | 1 |
| Herbert, JM | 1 |
| Sick, PB | 1 |
| Brosteanu, O | 1 |
| Ulrich, M | 1 |
| Thiele, H | 1 |
| Niebauer, J | 1 |
| Busch, I | 1 |
| Schuler, G | 1 |
| Di Nisio, M | 1 |
| Bijsterveld, NR | 1 |
| Meijers, JC | 1 |
| Levi, M | 1 |
| Büller, HR | 1 |
| Peters, RJ | 1 |
| Wallaschofski, H | 1 |
| Lohmann, T | 1 |
| Hild, E | 1 |
| Kobsar, A | 1 |
| Siegemund, A | 1 |
| Spilcke-Liss, E | 1 |
| Hentschel, B | 1 |
| Stumpf, C | 1 |
| Daniel, WG | 1 |
| Garlichs, CD | 1 |
| Eigenthaler, M | 1 |
| Potapov, EV | 1 |
| Hetzer, R | 1 |
| Nielsen, AB | 1 |
| Bochsen, L | 1 |
| Linnemann, B | 1 |
| Schwonberg, J | 1 |
| Mani, H | 1 |
| Prochnow, S | 1 |
| Lindhoff-Last, E | 1 |
| Landolfi, R | 1 |
| Di Gennaro, L | 1 |
| Ikeda, Y | 1 |
| Holm, J | 1 |
| Hillarp, A | 1 |
| Erhardt, L | 1 |
| Berntorp, E | 1 |
| Scott, RG | 1 |
| Undas, A | 1 |
| Bazan-Socha, S | 1 |
| Swadzba, J | 1 |
| Musial, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Remote Ischemic Preconditioning on Myocardial Injury After Noncardiac Surgery in Patients at a High Risk of Cardiac Events[NCT05733208] | 766 participants (Anticipated) | Interventional | 2023-05-06 | Recruiting | |||
| ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery(TEG-CABG Trial):Does Intensified Postoperative Antiplatelet Therapy in Preoperatively Identified Hypercoagulable Patients Improve Outcome After CABG[NCT01046942] | Phase 3 | 250 participants (Anticipated) | Interventional | 2008-11-30 | Recruiting | ||
| [NCT00000614] | Phase 3 | 0 participants | Interventional | 1998-09-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for ticlopidine and Thrombophilia
| Article | Year |
|---|---|
Triple therapy: worth the risk?
Topics: Anticoagulants; Aspirin; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Factor Xa Inhibitor | 2018 |
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug | 2015 |
Perioperative Management to Reduce Cardiovascular Events.
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia; Anticoagulants; Arthroplasty, Replacement, Knee; Aspi | 2016 |
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioide | 2011 |
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention.
Topics: Abciximab; Aged; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Aspirin; Bl | 2004 |
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Aspirin; Clinical Trials as Topic; Clopidogrel; Co | 2005 |
[Antiplatelet therapy].
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clinic | 1999 |
8 trials available for ticlopidine and Thrombophilia
| Article | Year |
|---|---|
Primary thrombophilia in México X: a prospective study of the treatment of the sticky platelet syndrome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Blood Platelet Disorders; Child; Clopidogrel; F | 2015 |
Thrombelastographic haemostatic status and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial): assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients: study pr
Topics: Aspirin; Clinical Protocols; Clopidogrel; Coronary Artery Bypass; Humans; Platelet Aggregation Inhib | 2012 |
Activated clotting times in the setting of eptifibatide use during percutaneous coronary intervention.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Dr | 2002 |
Prothrombotic responses to exercise are little influenced by clopidogrel treatment.
Topics: Adenosine Diphosphate; Adult; Blood Platelets; Cell Adhesion; Clopidogrel; Cross-Over Studies; Exerc | 2004 |
Prospective randomized comparison of early and late results of a carbonized stent versus a high-grade stainless steel stent of identical design: the PREVENT Trial [corrected].
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Biocompatibl | 2005 |
Effects of clopidogrel on the rebound hypercoagulable state after heparin discontinuation in patients with acute coronary syndromes.
Topics: Acute Disease; Angina, Unstable; Anticoagulants; Antithrombin III; Clopidogrel; Heparin; Humans; Myo | 2005 |
Hypercoagulability and platelet inhibition after OPCAB. Randomized intervention with clopidogrel.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Clopidogrel; Coronary Artery Bypass, Off-Pump; Femal | 2007 |
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antigens; Aspirin; Brain Ischemia; Death, Sudden, Ca | 1999 |
22 other studies available for ticlopidine and Thrombophilia
| Article | Year |
|---|---|
Defining a Clopidogrel Response Cut-Off Value Using Light Transmission Aggregometry Before Pipeline Embolization of Unruptured Intracranial Aneurysms.
Topics: Adult; Aged; Aged, 80 and over; Clopidogrel; Databases, Factual; Dose-Response Relationship, Drug; E | 2018 |
Association Between Residual Platelet Reactivity on Clopidogrel Treatment and Severity of Coronary Atherosclerosis: Intrinsic Hypercoagulability as a Mediator.
Topics: Aged; Clopidogrel; Coronary Artery Disease; Coronary Restenosis; Drug-Eluting Stents; Female; Humans | 2019 |
'VASPFix' for measurement of VASP phosphorylation in platelets and for monitoring effects of P2Y12 antagonists.
Topics: Adenosine; Adenosine Diphosphate; Alprostadil; Biomarkers, Pharmacological; Blood Platelets; Buclade | 2014 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-4 | 2015 |
Microparticles and blood cells induce procoagulant activity via phosphatidylserine exposure in NSTEMI patients following stent implantation.
Topics: Aged; Aspirin; Blood Cells; Blood Coagulation; Cell-Derived Microparticles; Clopidogrel; Female; Hum | 2016 |
A thrombotic storm.
Topics: Aged; Alprazolam; Amines; Amputation, Surgical; Atorvastatin; Cyclohexanecarboxylic Acids; Female; G | 2017 |
Ask the doctor. In October 2007, I had three Cypher stents placed in my left anterior descending artery. My doctor told me to take Plavix and aspirin indefinitely. Now I need to have a hernia repaired. My surgeon refuses to operate while I'm taking Plavix
Topics: Aspirin; Clopidogrel; Contraindications; Platelet Aggregation Inhibitors; Stents; Thoracic Surgery; | 2008 |
Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Female; Fibrinol | 2009 |
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; | 2009 |
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation".
Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinica | 2009 |
Positional brain ischemia with MCA occlusion successfully treated with extra-intracranial bypass.
Topics: Aspirin; Cerebral Revascularization; Clopidogrel; Humans; Infarction, Middle Cerebral Artery; Ischem | 2010 |
Clinical and angiographic outcomes with sirolimus-eluting stent for coronary bifurcation lesions. The J-PMS study.
Topics: Angioplasty; Aspirin; Calcinosis; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coro | 2011 |
Thrombus formation on a left atrial appendage closure device.
Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; | 2011 |
Thrombophilic causes of retinal vascular thrombosis: etiology and treatment outcomes.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspirin; Clinical Laboratory Techniques; Clopidogrel; Da | 2002 |
[New antiplatelet agents (platelet receptor blockers): has aspirin come out of place?].
Topics: Aspirin; Clinical Trials as Topic; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Huma | 2004 |
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Clopidogrel; Coronary Stenosis; Coronary Thrombosis; Drug A | 2005 |
Enhanced platelet activation by prolactin in patients with ischemic stroke.
Topics: Aged; Aged, 80 and over; Aspirin; Brain Ischemia; Clopidogrel; Female; Humans; Ischemic Attack, Tran | 2006 |
Impact of PlA polymorphism of platelet GP IIb/IIIa receptors on clinical course during long-term LVAD support is independent of type of LVAD.
Topics: Anticoagulants; Antigens, Human Platelet; Aspirin; Clopidogrel; Equipment Design; Genetic Predisposi | 2006 |
Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary.
Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Algorithms; Arachidonic Acid; Aspirin; Calibr | 2008 |
Prevention of thrombosis in polycythemia vera and essential thrombocythemia.
Topics: Arterial Occlusive Diseases; Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; | 2008 |
Stasis ulcers refractory to therapy--accelerated healing by treatment with clopidogrel +/- dalteparin: a preliminary report.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Antiphospholipid Syndrome; Clopidogrel; Dalteparin; | 2001 |
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report.
Topics: Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Autoantibodies; Factor V; Female; Humans; Is | 2002 |